产品名称
抗-U1-70K抗体,克隆9C4.1, clone 9C4.1, from mouse
biological source
mouse
conjugate
unconjugated
antibody form
purified antibody
antibody product type
primary antibodies
clone
9C4.1, monoclonal
species reactivity
rat, mouse, human
technique(s)
immunocytochemistry: suitable
western blot: suitable
isotype
IgG2aκ
NCBI accession no.
UniProt accession no.
shipped in
wet ice
target post-translational modification
unmodified
Quality Level
Gene Information
human ... SNRNP70(6625)
Analysis Note
对照
HeLa细胞裂解液
HeLa细胞裂解液
通过蛋白质印迹法在HeLa细胞裂解液中进行了评估。
蛋白质印迹分析:0.5 µg/mL该抗体可在10 µg HeLa细胞裂解液中检测到U1-70K。
蛋白质印迹分析:0.5 µg/mL该抗体可在10 µg HeLa细胞裂解液中检测到U1-70K。
Application
使用在WB、ICC中验证的抗U1-70K抗体,克隆9C4.1(小鼠单克隆抗体)检测U1-70K,也称为核小核糖核蛋白70kDa(U1)。
免疫细胞化学分析: 已显示该抗体代表性批次的1:500稀释液可在NIH/3T3、A431和HeLa细胞中检测到U1-70K。
研究子范畴
RNA代谢&结合蛋白
RNA代谢&结合蛋白
研究类别
表观遗传学&核功能
表观遗传学&核功能
Biochem/physiol Actions
该抗体可识别C端结构域处的U1-70K。
Disclaimer
除非我们的产品目录或产品附带的其他公司文档另有说明,否则我们的产品仅供研究使用,不得用于任何其他目的,包括但不限于未经授权的商业用途、体外诊断用途、离体或体内治疗用途或任何类型的消费或应用于人类或动物。
General description
U1小核糖核蛋白70 kDa(U1-70K)是在U1 snRNP核心中发现的三种特定蛋白之一,其中包括在所有U snRNP中发现的至少七种核心蛋白和三种特定蛋白:U1-70K,U1-A和U1-C。U1-70K通过将U1-snRNA的环I区与其RPM(RNA识别基序)结合域结合,参与介导前mRNA剪接。此外,其RNA结合结构域U1-70K还包含两个富含精氨酸的区域,这些区域带有酸性或丝氨酸残基,被认为具有反式作用。选择性剪接产生4种已知的亚型。截短形式的U1-70K无法结合RNA。
计算值 52 kDa 观测值 ~57 kDa
Immunogen
对应于人U1-70K的C末端结构域的重组蛋白。
表位:C端结构域
Other Notes
浓度:请参考批次特异性浓缩物的分析证书。
Physical form
形式:纯化
纯化的小鼠单克隆IgG2aκ,溶于含有0.1 M Tris-甘氨酸(pH 7.4,150 mM NaCl)和0.05%叠氮化钠的缓冲液中。
蛋白G纯化
Preparation Note
自收到之日起,在2-8°C条件下可稳定保存1年。
未找到合适的产品?
试试我们的产品选型工具.
存储类别
12 - Non Combustible Liquids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
1,25(OH)2D2 production by T lymphocytes and alveolar macrophages recovered by lavage from normocalcemic patients with tuberculosis.
J Cadranel,M Garabedian,B Milleron,H Guillozo,G Akoun,A J Hance
The Journal of Clinical Investigation null
Isaac Bishof et al.
The Journal of biological chemistry, 293(28), 11047-11066 (2018-05-29)
The U1 small nuclear ribonucleoprotein 70 kDa (U1-70K) and other RNA-binding proteins (RBPs) are mislocalized to cytoplasmic neurofibrillary Tau aggregates in Alzheimer's disease (AD), yet the co-aggregation mechanisms are incompletely understood. U1-70K harbors two disordered low-complexity domains (LC1 and LC2)
Suryasree Subramania et al.
Nucleic acids research, 47(8), 4181-4197 (2019-02-16)
Src associated in mitosis (SAM68) plays major roles in regulating RNA processing events, such as alternative splicing and mRNA translation, implicated in several developmental processes. It was previously shown that SAM68 regulates the alternative splicing of the mechanistic target of
Chloe K Nagasawa et al.
RNA (New York, N.Y.), 30(7), 824-838 (2024-04-05)
Forkhead box P3 (FOXP3) is the master fate-determining transcription factor in regulatory T (Treg) cells and is essential for their development, function, and homeostasis. Mutations in FOXP3 cause immunodysregulation polyendocrinopathy enteropathy X-linked (IPEX) syndrome, and aberrant expression of FOXP3 has
Therapeutic manipulation of IKBKAP mis-splicing with a small molecule to cure familial dysautonomia.
Masahiko Ajiro et al.
Nature communications, 12(1), 4507-4507 (2021-07-25)
Approximately half of genetic disease-associated mutations cause aberrant splicing. However, a widely applicable therapeutic strategy to splicing diseases is yet to be developed. Here, we analyze the mechanism whereby IKBKAP-familial dysautonomia (FD) exon 20 inclusion is specifically promoted by a
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持